Showing results (11-20 of 181) with videos related to

Sort By:
Pageof 19
Pharmacogenomics|December 16, 2014
Pharmacogenomics of antimicrobial agentsAr Kar Aung, David W Haas, Todd Hulgan, et al.
HIV Clinical Trials|September 3, 2009
Effect of HIV-1 infection on human DNA yield from salivaRebecca J Basham, Danielle M Richardson, Cara B Sutcliffe, et al.
Pharmacogenomics|May 12, 2026
Pharmacogenomics of current antiretroviral drugsJessica H Taylor, Hannah M Gunter, David W Haas, et al.
AIDS Research and Human Retroviruses|October 17, 2020
IFNL4 Genotype Does Not Associate with CD4 T-Cell Recovery in People Living with Human Immunodeficiency VirusEric G Meissner, Dongjun Chung, Betty Tsao, et al.
The Journal of Experimental Medicine|April 3, 2002
CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infectionAlison Motsinger, David W Haas, Aleksandar K Stanic, et al.
Plos One|December 19, 2013
Genetic and non-genetic determinants of raltegravir penetration into cerebrospinal fluid: a single arm pharmacokinetic studyDaniel H Johnson, Deborah Sutherland, Edward P Acosta, et al.
Personalized Medicine|May 17, 2018
Patient willingness to undergo efavirenz dose reduction based on pharmacogenetic testingMargaret Mitchell, Caroline Wells, Xuechao Zhang, et al.
Journal of Clinical Microbiology|February 5, 2002
Rapidly increasing prevalence of penicillin-resistant Streptococcus pneumoniae in middle Tennessee: a 10-year clinical and molecular analysisYi-Wei Tang, Haijing Li, Jane P Griffin, et al.
The Journal of Antimicrobial Chemotherapy|April 4, 2014
Functional CYP2B6 variants and virologic response to an efavirenz-containing regimen in Port-au-Prince, HaitiDavid W Haas, Patrice Severe, Marc Antoine Jean Juste, et al.
Pageof 19